Conference item : Abstract
Pivotal studies of pharmacotherapies approved by the United States Food and Drug Administration for the treatment of cancer: a systematic review
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 51.8KB, Terms of use)
-
- Publisher copy:
- 10.1200/jco.2025.43.16_suppl.e23125
Authors
+ NIHR Evaluation Trials and Studies Coordinating Centre
More from this funder
- Funder identifier:
- https://ror.org/03d7d0579
- Grant:
- 10/80/01
+ National Institute for Health and Care Research
More from this funder
- Funder identifier:
- https://ror.org/0187kwz08
- Grant:
- RP-PG-0615-20002
- NF-SI-0617-10057
- Publisher:
- American Society of Clinical Oncology
- Journal:
- Journal of Clinical Oncology More from this journal
- Volume:
- 43
- Issue:
- S16
- Article number:
- e23125
- Publication date:
- 2025-05-28
- Acceptance date:
- 2025-03-25
- Event title:
- 2025 ASCO Annual Meeting
- Event location:
- Chicago, IL, SUA
- Event website:
- https://meetings.asco.org/meetings/2025-asco-annual-meeting/327/program-guide/scheduled-sessions
- Event start date:
- 2025-05-30
- Event end date:
- 2025-06-03
- DOI:
- EISSN:
-
1527-7755
- ISSN:
-
0732-183X
- Language:
-
English
- Subtype:
-
Abstract
- Pubs id:
-
2129135
- Local pid:
-
pubs:2129135
- Deposit date:
-
2026-02-10
- ARK identifier:
Terms of use
- Copyright holder:
- American Society of Clinical Oncology
- Copyright date:
- 2025
- Rights statement:
- © 2025 by American Society of Clinical Oncology.
If you are the owner of this record, you can report an update to it here: Report update to this record